Source:http://linkedlifedata.com/resource/pubmed/id/12216100
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
2002-9-6
|
| pubmed:abstractText |
Leptomeningeal disease (LMD) involves the spread of malignant cells from solid tumors to the cerebrospinal fluid or to the leptomeninges. LMD has a very poor prognosis and it is difficult to diagnose and follow with traditional diagnostic tools. The purposes of this study were to characterize cognitive functioning of LMD patients before treatment and to determine if measurement of cognitive functioning could be used to predict survival time.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
AIM
|
| pubmed:status |
MEDLINE
|
| pubmed:month |
Sep
|
| pubmed:issn |
0008-543X
|
| pubmed:author | |
| pubmed:copyrightInfo |
Copyright 2002 American Cancer Society.
|
| pubmed:issnType |
Print
|
| pubmed:day |
15
|
| pubmed:volume |
95
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
1311-6
|
| pubmed:dateRevised |
2004-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:12216100-Cognition,
pubmed-meshheading:12216100-Humans,
pubmed-meshheading:12216100-Meningeal Neoplasms,
pubmed-meshheading:12216100-Meninges,
pubmed-meshheading:12216100-Mental Status Schedule,
pubmed-meshheading:12216100-Neuropsychological Tests,
pubmed-meshheading:12216100-Prognosis
|
| pubmed:year |
2002
|
| pubmed:articleTitle |
Pretreatment cognitive performance predicts survival in patients with leptomeningeal disease.
|
| pubmed:affiliation |
Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston 77030, USA.
|
| pubmed:publicationType |
Journal Article
|